NCT03062618View on ClinicalTrials.gov

A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 20, 2017

Primary Completion Date

February 8, 2018

Study Completion Date

February 8, 2018

Conditions
Psoriasis
Interventions
DRUG

PRCL-02

Oral tablet(s) administered with water

DRUG

Placebo Oral Tablet

Administered with water

Trial Locations (6)

V3R 6A7

Dr. Chih-ho Hong Medical Inc, Surrey

L3P 1X2

Lynde Centre for Dermatology, Markham

K9J 5K2

SKiN Centre for Dermatology, Peterborough

N2J 1C4

K Papp Clinical Research, Waterloo

H3Z 2S6

Centre de Dermatologie et Chirurgie Dermatologique, Montreal

G1P 0A2

InVentiv Health, Québec

Sponsors

Lead Sponsor

PRCL Research Inc.
All Listed Sponsors
lead

PRCL Research Inc.

OTHER

NCT03062618 - A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis | Biotech Hunter | Biotech Hunter